BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37200033)

  • 21. Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.
    Keller S; Yang M; Treadwell MJ; Hassell KL
    Health Qual Life Outcomes; 2017 Jun; 15(1):117. PubMed ID: 28577358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain Crises.
    Segbefia C; Campbell J; Tartaglione I; Asare EV; Andemariam B; Zempsky W; Colombatti R; Boatemaa GD; Boruchov D; Rao S; Piccone CM; Smith A; Haile H; Kim E; Wilson S; Farooq F; Urbonya R; Rivers A; Manwani D; Gai J; Sey F; Inusa B; Antwi-Boasiako C; Strunk C; Campbell AD
    J Womens Health (Larchmt); 2023 Dec; 32(12):1284-1291. PubMed ID: 38011013
    [No Abstract]   [Full Text] [Related]  

  • 23. A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study.
    Creary S; Chisolm D; Stanek J; Hankins J; O'Brien SH
    JMIR Mhealth Uhealth; 2019 Aug; 7(8):e13452. PubMed ID: 31397291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Hydroxyurea Therapy in Reducing Pain Crises, Hospital Admissions, and Length of Stay Among Sickle Cell Patients in the Eastern Region of Saudi Arabia.
    Albohassan H; Ammen M; Alomran AA; Bu Shehab H; Al Sakkak H; Al Bohassan A
    Cureus; 2022 Nov; 14(11):e31527. PubMed ID: 36540486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care.
    Kanter J; Gibson R; Lawrence RH; Smeltzer MP; Pugh NL; Glassberg J; Masese RV; King AA; Calhoun C; Hankins JS; Treadwell M
    JAMA Netw Open; 2020 May; 3(5):e206016. PubMed ID: 32469413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.
    Badawy SM; Thompson AA; Penedo FJ; Lai JS; Rychlik K; Liem RI
    Eur J Haematol; 2017 Jun; 98(6):608-614. PubMed ID: 28306171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
    Fortin PM; Fisher SA; Madgwick KV; Trivella M; Hopewell S; Doree C; Estcourt LJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012349. PubMed ID: 29737522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Disease-Modifying Treatments in Patients With Sickle Cell Disease.
    Newman TV; Yang J; Suh K; Jonassaint CR; Kane-Gill SL; Novelli EM
    JAMA Netw Open; 2023 Nov; 6(11):e2344546. PubMed ID: 37991760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnesium for treating sickle cell disease.
    Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthcare utilization and hydroxyurea adherence in youth with sickle cell disease.
    Badawy SM; Thompson AA; Holl JL; Penedo FJ; Liem RI
    Pediatr Hematol Oncol; 2018; 35(5-6):297-308. PubMed ID: 30636474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease.
    Rizio AA; Bhor M; Lin X; McCausland KL; White MK; Paulose J; Nandal S; Halloway RI; Bronté-Hall L
    Qual Life Res; 2020 Jun; 29(6):1533-1547. PubMed ID: 31933113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of patient-reported outcomes in sickle cell disease within a conceptual model.
    Treadwell MJ; Mushiana S; Badawy SM; Preiss L; King AA; Kroner B; Chen Y; Glassberg J; Gordeuk V; Shah N; Snyder A; Wun T;
    Qual Life Res; 2022 Sep; 31(9):2681-2694. PubMed ID: 35445915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of menstrual health in adolescent and young adults with sickle cell disease.
    Notice B; Soffer E; Tickle K; Xiang Y; Gee BE; Sidonio RF; Sokkary N; Batsuli G
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30727. PubMed ID: 37845801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.
    Han J; Bhat S; Gowhari M; Gordeuk VR; Saraf SL
    Pharmacotherapy; 2016 Nov; 36(11):1166-1172. PubMed ID: 27639254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive deficits are associated with unemployment in adults with sickle cell anemia.
    Sanger M; Jordan L; Pruthi S; Day M; Covert B; Merriweather B; Rodeghier M; DeBaun M; Kassim A
    J Clin Exp Neuropsychol; 2016 Aug; 38(6):661-71. PubMed ID: 27167865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease.
    Longoria JN; Pugh NL; Gordeuk V; Hsu LL; Treadwell M; King AA; Gibson R; Kayle M; Crego N; Glassberg J; Melvin CL; Hankins JS; Porter J
    Am J Hematol; 2021 Nov; 96(11):1396-1406. PubMed ID: 34350622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.